Patientswith Cardiovascular Events | Patients without Cardiovascular Events | ||
---|---|---|---|
(n = 80 ) | (n = 234) | p value | |
Basic characteristics | |||
   Male, n (%) | 59 (73.8) | 182 (78.1) | 0.44 |
   Age, year | 64 ± 11 | 64 ± 10 | 0.91 |
   Body-mass index, kg/m2 | 23.5 ± 2.8 | 23.7 ± 2.8 | 0.71 |
   Family history of IHD, n (%) | 26 (32.5) | 68 (29.2) | 0.58 |
   History of smoking, n (%) | 58(72.5) | 177 (76.0) | 0.55 |
   Clinical history | |||
Hypertension, n (%) | 45 (56.3) | 144 (61.8) | 0.43 |
Hyperlipidemia, n (%) | 52 (65.0) | 137 (58.8) | 0.36 |
Heart failure, n (%) | 1 (1.3) | 3 (1.3) | >0.99 |
Cerebrovascular disease, n (%) | 4 (5.0) | 14 (6.0) | >0.99 |
Chronic renal failure, n (%) | 2 (2.5) | 10 (4.3) | 0.74 |
ASO, n (%) | 6 (7.5) | 9 (3.9) | 0.22 |
Chronic obstructive pulmonary disease, n (%) | 1 (1.3) | 7 (3.0) | 0.69 |
Malignancy, n (%) | 5 (6.3) | 12 (5.2) | 0.78 |
   Previous procedures (PTCA/CABG), n (%) | 6 (7.5) | 10 (4.3) | 0.25 |
Laboratory data at the time of admission | |||
   Fasting blood sugar, mg/dL | 95 ± 9 | 94 ± 10 | 0.45 |
   Blood sugar after 2 h, mg/dL | 172 ± 51 | 160 ± 49 | 0.07 |
   HbA1c, % | 5.4 ± 0.5 | 5.4 ± 0.4 | 0.75 |
   Total Cholesterol, mg/dL | 198 ± 34 | 194 ± 38 | 0.34 |
   Triglyceride, mg/dL | 109 ± 73 | 107 ± 71 | 0.85 |
   LDL-Cholesterol, mg/dL | 134 ± 34 | 128 ± 34 | 0.18 |
   HDL-Cholesterol, mg/dL | 42 ± 9 | 44 ± 15 | 0.16 |
   Serum creatinine, mg/dL | 0.8 ± 0.2 | 0.8 ± 0.3 | 0.66 |
   Urea acid, mg/dL | 5.4 ± 1.6 | 5.5 ± 1.5 | 0.75 |
Characteristics of acute myocardial infarction | |||
   Systolic blood pressure on admission, mmHg | 136 ± 26 | 138 ± 23 | 0.65 |
   Heart rate on admission, bpm/m | 77 ± 18 | 73 ± 16 | 0.14 |
   Killip class≦‖, n (%) | 7 (8.8) | 11 (4.7) | 0.26 |
   Anterior MI, n (%) | 42 (52.5) | 108 (46.4) | 0.37 |
   Multi-vessel disease, n (%) | 42 (52.5) | 104 (44.6) | 0.24 |
   Procedural features | |||
Thrombolysis, n (%) | 12 (15.0) | 30 (12.9) | 0.7 |
Primary PTCA/CABG, n (%) | 47 (58.8) | 158 (67.8) | 0.17 |
Stent implantation, n (%) | 63 (78.8) | 178 (76.4) | 0.75 |
   LVEF, % | 42.2 ± 8.5 | 44.0 ± 8.2 | 0.11 |
   Peak CPK, U/L | 2965 ± 1836 | 2857 ± 2154 | 0.71 |
Medications | |||
   Aspirin, n (%) | 79 (98.8) | 227 (97.4) | 0.68 |
   ACEI/ARB, n (%) | 59 (73.8) | 171 (73.4) | >0.99 |
   Beta-blockers, n (%) | 53 (66.3) | 125 (53.6) | 0.07 |
   Statin, n (%) | 37 (46.3) | 112 (48.1) | 0.8 |
   Oral hypoglycemic agents, n (%) | 1 (1.3) | 1 (0.4) | 0.45 |